v3.26.3
Restatement of Financial Statements (Tables)
12 Months Ended
Dec. 31, 2025
Table Text Block Supplement [Abstract]  
Schedule of Restated Consolidated Balance Sheet

 

As of December 31, 2025

 

 

As Previously
Reported

 

 

Adjustments

 

 

As Restated

 

Assets:

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

12,848

 

 

 

(2,672

)

 

 

10,176

 

Other current assets

 

 

1,148

 

 

 

262

 

 

 

1,410

 

Total current assets

 

 

48,334

 

 

 

(2,410

)

 

 

45,924

 

Natural gas and oil mineral interests, net - successful
   efforts method

 

 

461,511

 

 

 

(925

)

 

 

460,586

 

Total assets

 

$

510,473

 

 

$

(3,335

)

 

$

507,138

 

Liabilities, mezzanine equity and shareholders’
   equity:

 

 

 

 

 

 

 

 

 

Deferred tax liability

 

 

22,109

 

 

 

(780

)

 

 

21,329

 

Total liabilities

 

 

271,502

 

 

 

(780

)

 

 

270,722

 

Accumulated deficit

 

 

(12,591

)

 

 

(2,555

)

 

 

(15,146

)

Total shareholders’ equity

 

 

211,309

 

 

 

(2,555

)

 

 

208,754

 

Total liabilities, mezzanine equity and
   shareholders’ equity

 

$

510,473

 

 

$

(3,335

)

 

$

507,138

 

Schedule of Restated Consolidated Statements of Operations

 

For the Year Ended December 31, 2025

 

 

As Previously
Reported

 

 

Adjustments

 

 

As Restated

 

Revenues:

 

 

 

 

 

 

 

 

 

Royalty revenue

 

$

55,691

 

 

$

(5,616

)

 

$

50,075

 

Total revenue

 

 

73,211

 

 

 

(5,616

)

 

 

67,595

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Management fees

 

 

9,274

 

 

 

692

 

 

 

9,966

 

Depletion, depreciation and accretion

 

 

26,948

 

 

 

(2,711

)

 

 

24,237

 

Total operating expenses

 

 

52,807

 

 

 

(2,019

)

 

 

50,788

 

Operating income (loss)

 

 

20,404

 

 

 

(3,597

)

 

 

16,807

 

Income (loss) before income taxes

 

 

(2,628

)

 

 

(3,597

)

 

 

(6,225

)

Provision for (benefit from) income taxes

 

 

(1,598

)

 

 

(1,042

)

 

 

(2,640

)

Net income (loss)

 

$

(1,030

)

 

$

(2,555

)

 

$

(3,585

)

Earnings(loss) per common share:

 

 

 

 

 

 

 

 

 

Common shares - basic and diluted

 

$

(1.00

)

 

$

(0.30

)

 

$

(1.30

)

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

Common shares - basic and diluted

 

 

8,378

 

 

 

—

 

 

 

8,378

 

Schedule of Restated Consolidated Statement of Cash Flows

 

As of December 31, 2025

 

 

As Previously
Reported

 

 

Adjustments

 

 

As Restated

 

Cash flow from operating activities:

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(1,030

)

 

$

(2,555

)

 

$

(3,585

)

Adjustments to reconcile net income (loss) to net cash
   provided by operating activities:

 

 

 

 

 

 

 

 

 

Depletion, depreciation and accretion

 

 

26,948

 

 

 

(2,711

)

 

 

24,237

 

Deferred income taxes

 

 

(2,728

)

 

 

(780

)

 

 

(3,508

)

Changes in operating assets and liabilities (net of
   assets and liabilities acquired)

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(3,235

)

 

 

2,673

 

 

 

(562

)

Other current assets

 

 

411

 

 

 

(262

)

 

 

149

 

Net cash provided by (used in) operating
   activities

 

 

17,212

 

 

 

(3,635

)

 

 

13,577

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchases of oil and gas properties, net of post-close
   adjustments

 

 

(118,977

)

 

 

3,635

 

 

 

(115,342

)

Net cash provided by (used in) investing
   activities

 

 

(313,593

)

 

 

3,635

 

 

 

(309,958

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) financing
   activities

 

 

320,040

 

 

 

—

 

 

 

320,040

 

Net increase (decrease) in cash and cash equivalents

 

 

23,659

 

 

 

—

 

 

 

23,659

 

Cash and cash equivalents, beginning of period

 

 

5,330

 

 

 

—

 

 

 

5,330

 

Cash and cash equivalents, end of period

 

$

28,989

 

 

$

—

 

 

$

28,989